Last edition
News about "RevOpsis Therapeutics "
ExSight Ventures Invests in RevOpsis Therapeutics to Develop Eye Disease Therapies
RevOpsis is developing a novel class of multi-specific antibody-based treatments designed to address significant unmet needs in ophthalmology, with an initial focus on wet Age-related Macular Degeneration (AMD) and diabetic eye disease.
RevOpsis Therapeutics | 17/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members